Skip to main content

Mountain Crest Acquisition Corp. V

corporate_fare Company Profile

Mountain Crest Acquisition Corp. V

MCAG·OTC·Industrial Applications And Services·CIK 0001859035

Mountain Crest Acquisition Corp. V is a blank check company, also known as a Special Purpose Acquisition Company (SPAC), formed in Delaware on April 8, 2021. The company's primary purpose is to complete an initial business combination, such as a merger, share exchange, asset acquisition, share purchase, or reorganization, with one or more existing businesses. While there are no strict limitations on industry or geographic region, Mountain Crest intends to target businesses primarily located in North America and the Asia Pacific regions, specifically excluding China (including Hong Kong and Macau). The company will not pursue an initial business combination with a target business whose principal operations are in China. On October 19, 2022, Mountain Crest entered into a Business Combination Agreement with AUM Biosciences Pte. Ltd., a private company incorporated in Singapore (company registration 201810204D). This agreement was subsequently amended on February 10, 2023, March 30, 2023, and April 19, 2023. On January 27, 2023, AUM Biosciences Limited (a Cayman Islands exempted company), AUM Biosciences Subsidiary Pte. Ltd. (a Singaporean company, registration 202238778Z, and a wholly-owned subsidiary of Holdco), and AUM Biosciences Delaware Merger Sub, Inc. (a Delaware corporation and a wholly-owned subsidiary of Holdco) joined the Business Combination Agreement as parties. This agreement outlines the terms and conditions for the company's initial business combination.

Mountain Crest Acquisition Corp. V (OTC:MCAG) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 3 items for MCAG at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-05-15, rated 9/10. Across its 3 most recent items scored 7 or higher, the top rating is 9/10, with 2 rated 8 or above. Recent SEC coverage for MCAG spans 10-Q, 10-K.

Recent high-impact activity:

  • Going Concern Warning Persists Amid Ineffective Controls; SPAC Extends Business Combination Deadline
  • SPAC MCAG Faces 'Going Concern' Warning, Delisted to OTC Amidst Zero Revenue in 10-K
  • Annual Report Reveals Going Concern Warning, Ineffective Controls, and Nasdaq Delisting Amidst CUBEBIO Merger Plans
Browse all tickers starting with M →
$13.27
52-week range · as of 2026-05-15 $9.69 – $13.27
Market cap
$38.13M
Volume
273 (0.1× avg)
3-mo avg 2.3K
Last traded · 2026-05-12

show_chartPrice Chart

Loading chart...

feed MCAG - Latest Insights

MCAG
May 15, 2026, 6:01 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $13.27
Real-time Price: $13.27 info
Change: $0 (0%) info
Market Cap: $38.125M info
MCAG
Mar 16, 2026, 6:05 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $12.29
Real-time Price: $13.27 info
Change: +$0.980 (+8%) info
Market Cap: $38.125M info
MCAG
Mar 13, 2026, 5:33 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $12.29
Real-time Price: $13.27 info
Change: +$0.980 (+8%) info
Market Cap: $38.125M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets